Universal-Beteiligungs- und Servicegesellschaft
CRNX icon

Universal-Beteiligungs- und Servicegesellschaft’s Crinetics Pharmaceuticals CRNX Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.5M Buy
425,616
+17,304
+4% +$773K 0.03% 465
2025
Q4 		$19M Buy
408,312
+20,387
+5% +$908K 0.03% 405
2025
Q3 		$16.2M Buy
387,925
+46,220
+14% +$1.48M 0.03% 449
2025
Q2 		$9.83M Sell
341,705
-1,029
-0.3% -$31.8K 0.02% 585
2025
Q1 		$11.5M Buy
342,734
+7,951
+2% +$297K 0.02% 526
2024
Q4 		$17.1M Buy
+334,783
New +$18.7M 0.03% 397

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's CRNX Position: Q1 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Crinetics Pharmaceuticals (CRNX) stake by 4.2% in Q1 2026, buying an estimated $773K and bringing the position to 425,616 shares worth $15.5M. The position accounts for 0.03% of the portfolio, ranked #465.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in CRNX in Q4 2024 and has held it in 6 quarters since. The position peaked at $19M in Q4 2025. 243 funds tracked by Wall St. Rank hold CRNX as of Q1 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 425,616 shares of Crinetics Pharmaceuticals worth $15.5M as of Q1 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 17,304 Crinetics Pharmaceuticals shares in Q1 2026, an estimated $773K.
  • Crinetics Pharmaceuticals made up 0.03% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q1 2026, its #465 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Crinetics Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Crinetics Pharmaceuticals position peaked at $19M in Q4 2025.
  • 243 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q1 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q1 2026, filed 11 May 2026.